Last 12 months
Inside the activity.
6 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 6 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 23, 2016 Filed Dec 28, 2016 21:08 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 27,000 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001170010-16-000234 · wf-form4_148295929299293.xml · derivative · entry 3 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 27,000 shares Expires 2019-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options vested in four equal installments on each of April 10, 2013, April 10, 2014, April 10, 2015, and April 10, 2016 and are now fully exercisable. Read SEC document |
| December 23, 2016 Filed Dec 28, 2016 21:08 UTC |
Reedy Thomas W JREVP & CFO
|
SaleCommon Stock | 27,000 | $64.02 | $1,728,540.00 |
DisclosureSEC source: 0001170010-16-000234 · wf-form4_148295929299293.xml · nonDerivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,183 F1 · price: The shares with respect to this transaction were sold at prices ranging from $64.00 to $64.08. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| December 23, 2016 Filed Dec 28, 2016 21:08 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionCommon Stock | 27,000 | $31.76 | $857,520.00 |
DisclosureSEC source: 0001170010-16-000234 · wf-form4_148295929299293.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 84,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 21:13 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionStock Options (Right to Buy) · Derivative | 3,000 | $0.00 Strike: $31.76 | $0.00 |
DisclosureSEC source: 0001170010-16-000230 · wf-form4_148252757772994.xml · derivative · entry 3 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,000 Underlying: Common Stock · 3,000 shares Expires 2019-04-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock options vested in four equal installments on each of April 10, 2013, April 10, 2014, April 10, 2015 and April 10, 2016 and are now fully exercisable. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 21:13 UTC |
Reedy Thomas W JREVP & CFO
|
SaleCommon Stock | 3,000 | $65.77 | $197,310.00 |
DisclosureSEC source: 0001170010-16-000230 · wf-form4_148252757772994.xml · nonDerivative · entry 2 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,183 F1 · price: The shares with respect to this transaction were purchased at prices ranging from $65.75 to $65.90. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares purchased at each separate price. Read SEC document |
| December 22, 2016 Filed Dec 23, 2016 21:13 UTC |
Reedy Thomas W JREVP & CFO
|
Exercise / conversionCommon Stock | 3,000 | $31.76 | $95,280.00 |
DisclosureSEC source: 0001170010-16-000230 · wf-form4_148252757772994.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,183 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 22, 2016 Filed Mar 30, 2017 20:22 UTC |
Reedy Thomas W JREVP & CFO
|
GiftCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-17-000029 · wf-form5_149090534269134.xml · nonDerivative · entry 1 Reedy Thomas W JR · CIK 0001504059 · EVP & CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,183 Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 20:23 UTC |
STANDLEY JOHN TDirector
|
GrantCommon Stock | 1,305 | $0.00 | $0.00 |
DisclosureSEC source: 0001170010-16-000211 · wf-form4_147509417437366.xml · nonDerivative · entry 1 STANDLEY JOHN T · CIK 0001233862 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,305 F1 · shares: These are restricted shares of common stock that will vest on the one-year anniversary of the grant date. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 20:22 UTC |
GARTEN JEFFREY EDirector
|
SaleCommon Stock | 6,300 | $53.41 | $336,483.00 |
DisclosureSEC source: 0001170010-16-000209 · wf-form4_147509414329154.xml · nonDerivative · entry 1 GARTEN JEFFREY E · CIK 0001181532 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,552 F1 · price: The shares with respect to this transaction were sold at prices ranging from $53.25 to $53.51. Upon request, the Reporting Person will provide the Securities and Exchange Commission staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each separate price. Read SEC document |
| September 26, 2016 Filed Sep 28, 2016 20:22 UTC |
Nash William DPresident & CEO
|
GrantStock Options (Right to Buy) · Derivative | 140,646 | $0.00 Strike: $53.62 | $0.00 |
DisclosureSEC source: 0001170010-16-000210 · wf-form4_147509415891317.xml · derivative · entry 1 Nash William D · CIK 0001545342 · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 140,646 Underlying: Common Stock · 140,646 shares Expires 2023-09-26 F1 · security: The stock options were granted in tandem with stock appreciation rights (SARS). Accordingly, the exercise of one results in the surrender to the Company of the other. The SARS become exercisable only following a change in control of the Company as set forth in the Company's 2002 Stock Incentive Plan, as amended and restated. Once exercisable, the SARS would entitle the Reporting Person to receive the cash value of the options in lieu of exercising the options. F2 · derivative.exercise_date: The stock options become exercisable with respect to one-fourth of the underlying shares of Common Stock on each of September 26, 2017, September 26, 2018, September 26, 2019 and September 26, 2020. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.